dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Manso, Luis |
dc.contributor.author | Hernando, Cristina |
dc.contributor.author | Antunes de Melo Oliveira, Ana Mafalda |
dc.contributor.author | Cabrera, Miguel A. |
dc.contributor.author | Bratos, Raquel |
dc.contributor.author | Galán, María |
dc.date.accessioned | 2021-10-01T08:06:13Z |
dc.date.available | 2021-10-01T08:06:13Z |
dc.date.issued | 2020-12-01 |
dc.identifier.citation | Manso L, Hernando C, Galán M, Oliveira M, Cabrera MA, Bratos R, et al. Palbociclib combined with endocrine therapy in heavily pretreated HR +/HER2 - advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP). Breast. 2020 Dec 1;54:286-92. |
dc.identifier.issn | 0960-9776 |
dc.identifier.uri | https://hdl.handle.net/11351/6372 |
dc.description | Càncer de mama avançat; Teràpia endocrina; Palbociclib |
dc.description.sponsorship | This study was sponsored by Biomedical Research Foundation of the Hospital Clínico San Carlos (Madrid, Spain). The study was funded by an investigator sponsored research grant (WI236789) from Pfizer. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Breast;54 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer |
dc.subject | Càncer - Hormonoteràpia |
dc.subject | Medicaments antineoplàstics - Ús terapèutic |
dc.subject.mesh | Antineoplastic Agents, Hormonal |
dc.subject.mesh | /therapeutic use |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | /drug therapy |
dc.title | Palbociclib combined with endocrine therapy in heavily pretreated HR + /HER2 - advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP) |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.breast.2020.11.005 |
dc.subject.decs | antineoplásicos hormonales |
dc.subject.decs | /uso terapéutico |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | /farmacoterapia |
dc.relation.publishversion | https://doi.org/10.1016/j.breast.2020.11.005 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Manso L] Hospital Universitario 12 de Octubre, Madrid, Spain. [Hernando C] Hospital Clínico Universitario de Valencia, Valencia, Spain. [Galán M] Hospital Universitario Son Llatzer, Palma, Spain. [Oliveira M] Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Cabrera MA] Hospital Universitario Nuestra Senora de Candelaria, Santa Cruz de Tenerife, Spain. [Bratos R] Hospital MD Anderson Cancer Center, Madrid, Spain |
dc.identifier.pmid | 33242755 |
dc.identifier.wos | 000604437000043 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |